# An Observational, Retrospective, UK & Ireland Audit of Patient Adherence to Rebif® Injections Using the RebiSmart™ Injection Device

> **NCT01601080** · — · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 230 (actual)

## Conditions studied

- Relapsing Multiple Sclerosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01601080
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-04
- **Primary completion:** 2012-10
- **Final completion:** —
- **Target enrollment:** 230 (ACTUAL)
- **Last updated:** 2014-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01601080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01601080, "An Observational, Retrospective, UK & Ireland Audit of Patient Adherence to Rebif® Injections Using the RebiSmart™ Injection Device". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01601080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*